185 related articles for article (PubMed ID: 2613392)
1. Theophylline pharmacokinetics in well-nourished and malnourished asthmatic children.
Kumar L; Garg SK; Singh S; Lal R; Shukla VK
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):588-92. PubMed ID: 2613392
[TBL] [Abstract][Full Text] [Related]
2. Theophylline clearance in undernourished asthma patients.
Raj NS; Misra A; Guleria R; Pande JN
Indian J Chest Dis Allied Sci; 1998; 40(3):175-8. PubMed ID: 9919837
[TBL] [Abstract][Full Text] [Related]
3. [Examination of theophylline pharmacokinetics during an attack of bronchial asthma in children].
Odajima Y
Arerugi; 1992 Jan; 41(1):22-8. PubMed ID: 1554321
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring of three delayed-release preparations of theophylline in the plasma of children: pharmacokinetic parameters and therapeutic significance].
Domínguez Granados R; Pita Calandre E; Girón Caro F; Gómez Rubio M; Molina Font JA
An Esp Pediatr; 1987 Nov; 27(5):357-61. PubMed ID: 3439657
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of a new slow-release theophylline preparation in asthmatic children].
Nieto A; Mazón A; Caballero L; Gil MC
An Esp Pediatr; 1985 Apr; 22(5):383-92. PubMed ID: 4014892
[TBL] [Abstract][Full Text] [Related]
6. [Theophylline in childhood asthma. Pharmacokinetic and clinical study (author's transl)].
Bellon G; Plasse JC; Satta S; Barbier Y; Gilly R
Rev Fr Mal Respir; 1981; 9(2):113-21. PubMed ID: 7255850
[TBL] [Abstract][Full Text] [Related]
7. Effect of ozagrel (OKY-046), a thromboxane synthetase inhibitor, on theophylline pharmacokinetics in asthmatic patients.
Kawakatsu K; Kino T; Yasuba H; Kawaguchi H; Tsubata R; Satake N; Oshima S
Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):158-63. PubMed ID: 2338368
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of theophylline in children with asthma.
Ellis EF; Koysooko R; Levy G
Pediatrics; 1976 Oct; 58(4):542-7. PubMed ID: 972795
[TBL] [Abstract][Full Text] [Related]
9. Linezolid pharmacokinetics in pediatric patients: an overview.
Jungbluth GL; Welshman IR; Hopkins NK
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S153-7. PubMed ID: 14520140
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics and pharmacodynamics of sustained-release theophylline formulation, Slo-bid, in both single and multiple dosing studies of asthmatic children].
Iwasaki E; Baba M
Arerugi; 1989 Mar; 38(3):263-71. PubMed ID: 2751433
[TBL] [Abstract][Full Text] [Related]
11. Use of pharmacokinetic profile in evaluating patients with repeatedly low theophylline concentrations.
Georgitis JW; Szefler SJ; Baswell B; Shen DD
Ann Allergy; 1984 Sep; 53(3):231-5. PubMed ID: 6476482
[TBL] [Abstract][Full Text] [Related]
12. Effect of type II diabetes mellitus on theophylline elimination.
Adithan C; Sriram G; Swaminathan RP; Krishnan M; Bapna JS; Chandrasekar S
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):258-60. PubMed ID: 2737793
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of pioglitazone in Thai healthy subjects.
Wittayalertpanya S; Chompootaweep S; Thaworn N
J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of the pharmacokinetics and urinary metabolites of sustained-release theophylline syrup, granule and tablet preparations].
Horiuchi Y; Takemura T; Ueno K
Arerugi; 1991 Sep; 40(9):1186-93. PubMed ID: 1958133
[TBL] [Abstract][Full Text] [Related]
16. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
Schaefers M; Richter O; Reinhardt D; Becker B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of theophylline in Ethiopian children of differing nutritional status.
Eriksson M; Paalzow L; Bolme P; Mariam TW
Eur J Clin Pharmacol; 1983; 24(1):89-92. PubMed ID: 6832207
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients].
Repetto T; Marianelli L; Valenza T; Rosselli P; Messori A
Pediatr Med Chir; 1985; 7(6):823-5. PubMed ID: 3837249
[TBL] [Abstract][Full Text] [Related]
19. Theophylline pharmacokinetics in Thai children.
Vichyanond P; Aranyanark N; Visitsuntorn N; Tuchinda M
Asian Pac J Allergy Immunol; 1994 Dec; 12(2):137-43. PubMed ID: 7612107
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
